TTIP
Pharma ‘spends €40m to sway EU politicians’
September 2, 2015Medical Communications EU, European Commission, TTIP, drug policy, lobbying, transparency
The pharma industry has excessive power over EU decision-makers and spends €40 million a year to influence EU drug policy, …
Latest content
The evidence bar impacting UK medical cannabis access
November 6, 2026
Addressing the rheumatic disease diagnostic gap in primary care
November 5, 2026
